Research and treatment timeline: 30+ years of ms milestones | 4
Research and treatment timeline: 30+ years of ms milestones | 4
Research and treatment timeline: 30+ years of ms milestones | 4
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>ms</strong> canada Fall/Winter 2012 2<br />
am <strong>of</strong>ten reminded,<br />
I during conversations<br />
with people living with<br />
multiple sclerosis,<br />
that hope for an end<br />
Yves savoie<br />
to MS can mean<br />
very different things<br />
to different people. Whether it’s hope for a<br />
cure or hope for more effective symptom<br />
management, we are hopeful that advances<br />
in research will one day <strong>of</strong>fer a means to an<br />
end to MS. This issue <strong>of</strong> MS Canada focuses<br />
on research, past <strong>and</strong> present. Through<br />
increasing our knowledge about multiple<br />
sclerosis we are hopeful that a future free <strong>of</strong><br />
this disease can exist.<br />
We welcome the federal government’s<br />
announcement that the Phase I/II clinical trial<br />
for chronic cerebrospinal venous insufficiency<br />
(CCSVI) has received the necessary medical<br />
<strong>and</strong> ethical approvals required to proceed.<br />
The national MS interventional clinical trial<br />
is a collaborative initiative between the<br />
Government <strong>of</strong> Canada, provinces where there<br />
are trial sites <strong>and</strong> the MS Society. We are<br />
hopeful that the research <strong>of</strong> Dr. Traboulsee<br />
<strong>and</strong> his collaborators will provide significant<br />
insights to those living with MS <strong>and</strong> provide<br />
answers on questions about CCSVI <strong>and</strong> MS.<br />
My sincerest thanks to those who provided<br />
feedback on the Renewal Initiative, a 12-month<br />
process <strong>of</strong> engagement that sought ways for<br />
Ms Canada, Fall/Winter 2012<br />
Published by the Multiple Sclerosis Society <strong>of</strong> Canada<br />
175 Bloor St. E., Suite 700, Toronto ON M4W 3R8<br />
Tel: (416) 922-6065 • Fax: (416) 922-7538<br />
Toll free: 1-866-922-6065 • Website: <strong>ms</strong>society.ca/<strong>ms</strong>canada<br />
Charitable Registration no. 10774 6174 RR0001<br />
Our Mission: To be a leader in finding a cure for multiple sclerosis<br />
<strong>and</strong> enabling people affected by MS to enhance their quality <strong>of</strong> life.<br />
President <strong>and</strong> chief executive <strong>of</strong>ficer: Yves Savoie<br />
Editor-in-chief: Tiffany Regaudie<br />
Managing editor: Krysta Celestine<br />
ISSN 0315-1131<br />
Canadian Publications Mail Product<br />
Sales Agreement No. 40063383<br />
Message from yves<br />
the MS Society to be more effective <strong>and</strong><br />
efficient in delivering upon its mission. To those<br />
who provided input during this process, please<br />
know that you have played a significant role<br />
in helping to ensure that we will continue to<br />
best serve those affected by MS. For up to date<br />
information on the Renewal Initiative please<br />
visit <strong>ms</strong>society.ca/renewal<br />
I am also pleased to announce the<br />
appointment <strong>of</strong> Owen Charters to the<br />
position <strong>of</strong> chief development <strong>of</strong>ficer (CDO)<br />
effective January 14, 2013. Owen has played<br />
significant leadership roles spanning from<br />
hospital foundations to member-based,<br />
multi-level national organizations. Owen<br />
served CanadaHelps as president <strong>and</strong> chief<br />
executive <strong>of</strong>ficer since 2007 <strong>and</strong> is currently<br />
adjunct faculty at the Schulich School <strong>of</strong><br />
Business at York University. Owen will provide<br />
strategic vision <strong>and</strong> dynamic leadership as<br />
the architect <strong>of</strong> the MS Society’s development<br />
<strong>and</strong> marketing progra<strong>ms</strong>.<br />
A note <strong>of</strong> recognition <strong>and</strong> gratitude is also<br />
extended to Genzyme, a San<strong>of</strong>i Company,<br />
for their support <strong>of</strong> this edition <strong>of</strong> MS Canada<br />
through an unrestricted educational grant. I<br />
have heard from people living with MS that<br />
research brings them hope. I share in this<br />
sentiment <strong>and</strong> hope that the future will also<br />
bring answers <strong>and</strong> a cure. ■<br />
Yves Savoie<br />
Attention! We would like to keep in touch<br />
via email. If you would like to receive future<br />
issues <strong>of</strong> MS Canada electronically instead<br />
<strong>of</strong> a printed version, please send your full<br />
name, current address <strong>and</strong> email address to<br />
<strong>ms</strong>canada@<strong>ms</strong>society.ca<br />
ON THE COVER: Dr. Jiwon Oh, winner <strong>of</strong><br />
the Decker Family endMS <strong>Research</strong> <strong>and</strong> Training<br />
Network Transitional Career Development Award